Enterprise record
Alpha ID: alpha:company:146b5dcc-6ee0-4bfc-a1af-bda1ddc3d58eVersion: public-1
18 published Claims3 sources
The enterprise, in context.
Connect capital, control, accountability, and evidence.
Governance priorities
Capital allocationInspect reported performance, cash generation, and investment.Board accountabilityWho holds each mandate, and what evidence supports it?Ownership & votingSeparate economic interests from voting authority.Key Claims
Board and committees
Financial statements
Published financial observations retain their reported values, periods, and sources. Coverage may be partial; this is not a reconstructed complete financial statement.
All financials coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageControl and shareholders
Control and shareholders coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageCompensation
Compensation coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAuditors, advisors and reporting
Auditors, advisors and reporting coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageLegal
Legal coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageAI governance
AI governance coverage
No published Claims are available in this section of the public record. This does not establish that the information is undisclosed or that no relevant facts exist.
Review evidence coverageEvidence, history and coverage
Additional published Claims
Published evidence records
3 evidence records, matching Agent View. Records may refer to different locations or observations in the same document. This count is not a count of independent corroborating sources.
Alpha canonical company public projection
canonical identity · Source published: Date unavailable · Retrieved: Oct 2, 2026
Supports 5 claims
- Legal Name: Bicara Therapeutics Inc. · Claim reviewed: Oct 2, 2026
- Entity Status: Public listing published · Claim reviewed: Oct 2, 2026
- Published Fact: US · Claim reviewed: Oct 2, 2026
- Published Fact: Healthcare · Claim reviewed: Oct 2, 2026
- Published Fact: Biotechnology · Claim reviewed: Oct 2, 2026
DEF 14A bcax-20260427.htm
sec proxy · Source published: Apr 27, 2026 · Retrieved: Sep 2, 2026
Supports 9 claims
- Leadership Role: Carolyn Ng: Director · Claim reviewed: Oct 2, 2026
- Leadership Role: Christopher Bowden: Director · Claim reviewed: Oct 2, 2026
- Leadership Role: Claire Mazumdar: Director · Claim reviewed: Oct 2, 2026
- Leadership Role: Jake Simson: Director · Claim reviewed: Oct 2, 2026
- Leadership Role: Kate Haviland: Director · Claim reviewed: Oct 2, 2026
- Leadership Role: Kiran Mazumdar-Shaw: Director · Claim reviewed: Oct 2, 2026
- Leadership Role: Michael Powell: Director · Claim reviewed: Oct 2, 2026
- Leadership Role: Ryan Cohlhepp: Director · Claim reviewed: Oct 2, 2026
- Leadership Role: Scott Robertson: Director · Claim reviewed: Oct 2, 2026
AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC
sec proxy · Source published: Date unavailable · Retrieved: Date unavailable
Supports 4 claims
- Committee Record: AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC: Chair Scott Robertson; Members Scott Robertson (Chair); Carolyn Ng; Michael Powell · Claim reviewed: Oct 2, 2026
- Committee Appointment: Scott Robertson: chair, AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC · Claim reviewed: Oct 2, 2026
- Committee Appointment: Carolyn Ng: member, AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC · Claim reviewed: Oct 2, 2026
- Committee Appointment: Michael Powell: member, AUDIT COMMITTEE OF THE BOARD OF DIRECTORS OF BICARA THERAPEUTICS INC · Claim reviewed: Oct 2, 2026
No published record changes are available in this projection.
Identity
unclaimed
Evidence
source reported
Evaluation
Unknown
Monitoring
Unknown
Authority
Unknown
Freshness
Observed 2026-10-02
- Board and committees
- published
- Financial statements
- not observed
- Control and shareholders
- not observed
- Compensation
- not observed
- Auditors, advisors and reporting
- not observed
- Legal
- not observed
- AI governance
- not observed